Ex Vivo News and Research

RSS
Aeras Global receives FDA grant to develop biomarkers for TB vaccine

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

Echo commences development of new transdermal biosensor for continuous lactate monitoring

Echo commences development of new transdermal biosensor for continuous lactate monitoring

Scientist develops nano-methods to destroy tumors with fewer side effects

Scientist develops nano-methods to destroy tumors with fewer side effects

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

Ethicon launches OMNEX Surgical synthetic sealant

Ethicon launches OMNEX Surgical synthetic sealant

Gamida Cell-Teva Joint Venture's StemEx program receives FDA Fast Track Designation

Gamida Cell-Teva Joint Venture's StemEx program receives FDA Fast Track Designation

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

Oncodesign announces technology license agreement with Janssen Pharmaceutica

Oncodesign announces technology license agreement with Janssen Pharmaceutica

Functional profiling using EVA/PCD for prescribing treatment regimens for Stage IV NSCLC improve survival

Functional profiling using EVA/PCD for prescribing treatment regimens for Stage IV NSCLC improve survival

AMT reports positive preclinical data from cholesterol targeting AAV gene therapy study

AMT reports positive preclinical data from cholesterol targeting AAV gene therapy study

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

Human stem cells restore alveolar epithelial tissue after E. coli endotoxin-induced ALI: Researchers

Human stem cells restore alveolar epithelial tissue after E. coli endotoxin-induced ALI: Researchers

FDA grants NeoPharm's IL13-PE38QQR orphan-drug designation for treatment of IPF

FDA grants NeoPharm's IL13-PE38QQR orphan-drug designation for treatment of IPF

BioMarker Strategies receives $1M NCI grant funding to develop SnapPath live tumor cell testing system

BioMarker Strategies receives $1M NCI grant funding to develop SnapPath live tumor cell testing system

Study results from US Military Malaria Vaccine Program announced

Study results from US Military Malaria Vaccine Program announced

NeoPharm seeks Orphan Drug Designation for IL13-PE38QQR in treatment of IPF

NeoPharm seeks Orphan Drug Designation for IL13-PE38QQR in treatment of IPF

Idera Pharmaceuticals announces net income of $3.9M for fourth-quarter 2009

Idera Pharmaceuticals announces net income of $3.9M for fourth-quarter 2009

BCRI study evaluates the effect of high-doses of vitamin C on inhibition of new blood vessel growth

BCRI study evaluates the effect of high-doses of vitamin C on inhibition of new blood vessel growth

Clive Svendsen to receive American Academy of Neurology Sheila Essey Award for his research on ALS

Clive Svendsen to receive American Academy of Neurology Sheila Essey Award for his research on ALS

Preliminary study results of ExThera Medical's Seraph extracorporeal affinity therapy published

Preliminary study results of ExThera Medical's Seraph extracorporeal affinity therapy published

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.